Status:
UNKNOWN
Concentration of MitoQ in Human Skeletal Muscle
Lead Sponsor:
University of Copenhagen
Conditions:
Healthy
Eligibility:
MALE
18-40 years
Phase:
NA
Brief Summary
The purpose of this study is to determine mitoquinone mesylate concentration levels in skeletal muscle samples obtained after intake of an acute oral dose of MitoQ.
Eligibility Criteria
Inclusion
- Healthy,
- Male
- 18-40 years of age
Exclusion
- Previous use of MitoQ or CoQ-10 within 30 days of screening appointment
- Ongoing use of MitoQ
- Smoking
- Ongoing treatment with medications
- Disease deemed by the MD to infer a risk to participate in the trial
Key Trial Info
Start Date :
September 8 2019
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 30 2020
Estimated Enrollment :
10 Patients enrolled
Trial Details
Trial ID
NCT04098510
Start Date
September 8 2019
End Date
September 30 2020
Last Update
September 23 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
August Krogh Building
Copenhagen, Denmark